Mark A Goldsmith Revolution Medicines, Inc. (RVMD) insider trading activity

Mark A Goldsmith is of Revolution Medicines, Inc.. Currently has a direct ownership of 300,170 shares of RVMD, which is worth approximately $17.3 Million. The most recent transaction as insider was on Feb 22, 2023, when has been sold 45,000 shares (Common Stock) at a price of $0.49 per share, resulting in proceeds of $22,050. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 300K

3.76% 3M change

21.9% 12M change

Total Value Held $17.3 Million

MARK A GOLDSMITH Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 22 2023	BUY Exercise of conversion of derivative security	$22,050 $0.49 p/Share	45,000 Added 15.16%	251,872 Common Stock
Aug 11 2022	BUY Exercise of conversion of derivative security	$4,900 $0.49 p/Share	10,000 Added 4.61%	206,872 Common Stock
Aug 09 2022	BUY Exercise of conversion of derivative security	$5,065 $0.49 p/Share	10,336 Added 4.99%	196,872 Common Stock
Mar 17 2022	SELL Open market or private sale	$19,038 $18.61 p/Share	1,023 Reduced 0.55%	185,599 Common Stock
Mar 01 2022	BUY Grant, award, or other acquisition	-	104,000 Added 35.79%	186,622 Common Stock
Dec 17 2021	SELL Open market or private sale	$38,348 $24.41 p/Share	1,571 Reduced 1.87%	82,622 Common Stock
Dec 06 2021	BUY Exercise of conversion of derivative security	$18,483 $0.49 p/Share	37,721 Added 30.94%	84,193 Common Stock
Sep 17 2021	SELL Open market or private sale	$45,961 $30.02 p/Share	1,531 Reduced 3.19%	46,472 Common Stock
Jun 17 2021	SELL Open market or private sale	$50,223 $33.82 p/Share	1,485 Reduced 3.0%	48,003 Common Stock
Mar 04 2021	BUY Grant, award, or other acquisition	-	48,000 Added 49.62%	48,744 Common Stock
Mar 01 2021	SELL Open market or private sale	$230,000 $46.0 p/Share	5,000 Reduced 87.05%	744 Common Stock
Mar 01 2021	BUY Exercise of conversion of derivative security	$5,600 $1.12 p/Share	5,000 Added 46.54%	5,744 Common Stock
Feb 05 2021	SELL Open market or private sale	$825,000 $55.0 p/Share	15,000 Reduced 95.27%	744 Common Stock
Feb 05 2021	BUY Exercise of conversion of derivative security	$16,800 $1.12 p/Share	15,000 Added 48.79%	15,744 Common Stock
Feb 02 2021	SELL Open market or private sale	$228,800 $45.76 p/Share	5,000 Reduced 87.05%	744 Common Stock
Feb 02 2021	BUY Exercise of conversion of derivative security	$5,600 $1.12 p/Share	5,000 Added 46.54%	5,744 Common Stock
Sep 30 2020	SELL Open market or private sale	$1,464,683 $34.4 p/Share	42,578 Reduced 100.0%	0 Common Stock
Sep 30 2020	BUY Exercise of conversion of derivative security	$124,754 $2.93 p/Share	42,578 Added 50.0%	42,578 Common Stock
Sep 29 2020	SELL Open market or private sale	$1,042,055 $34.14 p/Share	30,523 Reduced 100.0%	0 Common Stock
Sep 29 2020	BUY Exercise of conversion of derivative security	$134,606 $4.41 p/Share	30,523 Added 50.0%	30,523 Common Stock
Sep 28 2020	SELL Open market or private sale	$345,603 $34.11 p/Share	10,132 Reduced 100.0%	0 Common Stock
Sep 28 2020	BUY Exercise of conversion of derivative security	$41,440 $4.09 p/Share	10,132 Added 50.0%	10,132 Common Stock

Also insider at

CNST

CONSTELLATION PHARMACEUTICALS INC Healthcare

MAG

Mark A Goldsmith

Redwood City, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RVMD shares.

Notify only if

Value

Insider Trading

Get notified when an Revolution Medicines, Inc. insider buys or sells RVMD shares.

Notify only if

Operation

Value

Type

News

Receive news related to Revolution Medicines, Inc.

Track Activities on RVMD

Account